“…Therefore, it was considered that the antimetastatic effect of magnolol in vivo may be related to other mechanisms. Magnolol has been shown to have many biological activities such as an antiplatelet aggregation (Teng et al, 1988), hydroxyl radical scavenging (Fujita and Taira, 1994), Ca 2+ -channel blocking (Teng et al, 1990) and antiinflammation action (Hamasaki et al, 1999;Wang et al, 1995), and some of these findings play a role in the inhibition of metastasis. Tsuruo et al demonstrated that verapamil, a calcium channel antagonist, inhibits B16 melanoma liver metastasis model.…”